1. Home
  2. PRCH vs CSTL Comparison

PRCH vs CSTL Comparison

Compare PRCH & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRCH

Porch Group Inc.

HOLD

Current Price

$11.05

Market Cap

848.9M

Sector

Technology

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$24.70

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
CSTL
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
848.9M
806.3M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
PRCH
CSTL
Price
$11.05
$24.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$18.63
$45.50
AVG Volume (30 Days)
2.2M
269.9K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
N/A
EPS
N/A
N/A
Revenue
$482,414,000.00
$344,229,000.00
Revenue This Year
$4.15
$2.42
Revenue Next Year
$17.05
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
10.18
3.66
52 Week Low
$6.36
$14.59
52 Week High
$19.44
$44.28

Technical Indicators

Market Signals
Indicator
PRCH
CSTL
Relative Strength Index (RSI) 74.05 48.34
Support Level $8.93 $21.77
Resistance Level $16.67 $26.20
Average True Range (ATR) 0.71 1.01
MACD 0.35 0.18
Stochastic Oscillator 88.38 63.58

Price Performance

Historical Comparison
PRCH
CSTL

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: